FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Noven Pharmaceuticals Minivelle Recall

Minivelle (estradiol transdermal system) 0

Noven Pharmaceuticals, Inc. · Miami, FL

Risk level
Class II
Reported by FDA
Apr 22, 2015
Recall ID
D-0485-2015
Check your lot numberHow we source this data

Summary

Noven Pharmaceuticals recalled Minivelle starting Feb 25, 2015. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0485-2015 on Apr 22, 2015. Reason: Temperature Abuse: Prolonged exposure to temperatures outside of labeled storage conditions. Status: Terminated.

Why it was recalled

Temperature Abuse: Prolonged exposure to temperatures outside of labeled storage conditions.

Product description

Minivelle (estradiol transdermal system) 0.05 mg/day, 8-count box, Rx only, Manufactured by Noven Pharmaceuticals, Inc., Miami, Florida 33186, Distributed by Noven Pharmaceuticals, LLC, Miami, Florida 33186, NDC 68968-6650-8

Lot numbers, UPCs & expiration codes

Lot # 76476; Exp 07/16

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0485-2015
Classification
Class II
Status
Terminated
Recall initiated
Feb 25, 2015
FDA report date
Apr 22, 2015
Quantity
720 transdermal patches
Recall type
Voluntary: Firm initiated
Recalling firm
Noven Pharmaceuticals, Inc.

Original FDA data

Every field from FDA enforcement report D-0485-2015, exactly as published.

Show all FDA fields
City
Miami
State
FL
Status
Terminated
Country
United States
Event ID
70764
Address
11960 Sw 144th St
Code information
Lot # 76476; Exp 07/16
Postal code
33186-6109
Report date
Apr 22, 2015
Product type
Drugs
Recall number
D-0485-2015
Classification
Class II
Recalling firm
Noven Pharmaceuticals, Inc.
Product quantity
720 transdermal patches
Termination date
Feb 26, 2019
Reason for recall
Temperature Abuse: Prolonged exposure to temperatures outside of labeled storage conditions.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Minivelle (estradiol transdermal system) 0.05 mg/day, 8-count box, Rx only, Manufactured by Noven Pharmaceuticals, Inc., Miami, Florida 33186, Distributed by Noven Pharmaceuticals, LLC, Miami, Florida 33186, NDC 68968-6650-8
Distribution pattern
Nationwide
Recall initiation date
Feb 25, 2015
Initial firm notification
Letter
Center classification date
Apr 13, 2015

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0485-2015, published Apr 22, 2015. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls